Cyteir Therapeutics is based in Cambridge, Massachusetts. It has raised $140M in total funding. Latest round: Series C.
Cyteir Therapeutics is based in Cambridge, Massachusetts. Cyteir Therapeutics has raised $140M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series C announced in February 2021. The round record for Cyteir Therapeutics runs through 2021; nothing later has been disclosed. Investors on record include RA Capital Management, Janus Henderson Investors, Acuta Capital Partners, Ally Bridge Group, Avidity Partners, Novo Holdings and 4 others. 10 distinct backers are named across the disclosed rounds.
Totals shown for Cyteir Therapeutics aggregate every disclosed round on file. To see how that compares, browse the companies in Cambridge and the investors behind them below.
Company funding database · Investor directory · Founder database · Mega-rounds 2026